These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2532202)

  • 1. AIDS in Arkansas. AMS Special Committee on AIDS. Update December 1989: results of controlled clinical trials of zidovudine in early HIV infection.
    Jones WN
    J Ark Med Soc; 1989 Dec; 86(7):265-7. PubMed ID: 2532202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effectiveness of zidovudine].
    Mulder JW
    Ned Tijdschr Geneeskd; 1995 Feb; 139(5):211-3. PubMed ID: 7854480
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early treatment with zidovudine; a turning point in the campaign against AIDS?].
    Lange JM; Goudsmit J
    Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2599-601. PubMed ID: 2691897
    [No Abstract]   [Full Text] [Related]  

  • 4. Zidovudine in symptomless HIV infection.
    Lancet; 1989 Feb; 1(8635):415-6. PubMed ID: 2563790
    [No Abstract]   [Full Text] [Related]  

  • 5. [The progression of HIV infection slowed down. Studies with zidovudine--the blood picture changes].
    Biedermann-Hefner M
    Fortschr Med; 1990 Apr; 108(10):72. PubMed ID: 2341104
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical trials of zidovudine in HIV infection.
    Lancet; 1989 Aug; 2(8661):483-4. PubMed ID: 2570190
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B
    Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine treatment of AIDS and ARC in Denmark 1987.
    Teglbjaerg LL; Mathiesen LR; Søeberg B; Nielsen L; Thorsen B; Buhl M; Pedersen C; Bonnevie O; Nielsen C; Vestergaard BF
    Scand J Infect Dis; 1989; 21(4):367-73. PubMed ID: 2685984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Several aspects of HIV infections].
    Costantino M
    Minerva Chir; 1991 Oct; 46(20):1152. PubMed ID: 1766567
    [No Abstract]   [Full Text] [Related]  

  • 12. Zidovudine in asymptomatic HIV infection: knowledge and uncertainty.
    Pinching AJ
    Int J STD AIDS; 1991; 2(3):157-61. PubMed ID: 1863644
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS in Arkansas. AMS Special Committee on AIDS. Update: December 1987. Self-help for seropositive patients.
    Vollmer J
    J Ark Med Soc; 1987 Dec; 84(7):270-1. PubMed ID: 2962983
    [No Abstract]   [Full Text] [Related]  

  • 14. [AIDS. Trial with Retrovir for HIV-positive subjects].
    Vesterdal A
    Sygeplejersken; 1989 May; 89(18):10-3. PubMed ID: 2669201
    [No Abstract]   [Full Text] [Related]  

  • 15. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
    Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
    Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate versus deferred zidovudine.
    Peto R; Collins R
    Lancet; 1993 Apr; 341(8851):1022-3. PubMed ID: 8096900
    [No Abstract]   [Full Text] [Related]  

  • 17. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ups and downs--and ups in the antiviral therapy of HIV infection.
    Weller IV; Williams I
    Genitourin Med; 1996 Feb; 72(1):2-5. PubMed ID: 8655161
    [No Abstract]   [Full Text] [Related]  

  • 19. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS].
    de Gans J; Lange JM; Derix MM; de Wolf F; Ongerboer de Visser BW; Goudsmit J
    Ned Tijdschr Geneeskd; 1988 Sep; 132(36):1656-60. PubMed ID: 3050555
    [No Abstract]   [Full Text] [Related]  

  • 20. A critical analysis of recent data on zidovudine therapy: use in asymptomatic HIV infection and early HIV disease, dosing and resistance issues.
    Peto TE
    AIDS; 1990; 4 Suppl 1():S187-91. PubMed ID: 2152565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.